Evidence map›Paper›PMID 21078850›Full record

ArticleInfection and immunity2011

Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms.

Stefanie S V Henriet, Peter W M Hermans, Paul E Verweij, Elles Simonetti, Steven M Holland, Janyce A Sugui, Kyung J Kwon-Chung, Adilia Warris

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. BeyondAntimicrobial agents and chemotherapy · 2026
    Article
  2. Review
  3. Article
  4. NADPH oxidase 2 plays a protective role in experimentalInternational journal of ophthalmology · 2022
    Article
  5. Review
  6. Article
  7. Frontiers in immunology · 2020
    Article
  8. Article
  9. Article
  10. ERJ open research · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. NOX2-dependent regulation of inflammation.Clinical science (London, England : 1979) · 2016
    Review
  15. Article
  16. Review
  17. Treatment options in Invasive Aspergillosis.Current treatment options in infectious diseases · 2014
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Stefanie S V HenrietDepartment of Pediatrics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
Peter W M Hermans
Paul E Verweij
Elles Simonetti
Steven M Holland
Janyce A Sugui
Kyung J Kwon-Chung
Adilia Warris
Radboud University Medical Center · NLNational Institute of Allergy and Infectious Diseases · USRadboud University Nijmegen · NLNational Institutes of Health · US

Funding

Transgenic Animal Models Of Human Immune DefectsZIAAI000646 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOLLAND, STEVEN · 2009 to 2025
$22.2M
Basic Studies On Aspergillus SpeciesZIAAI000657 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KWON-CHUNG, KYUNG · 2009 to 2020
$4.3M
Intramural NIH HHS
6 · The paper itself

Abstract

Invasive aspergillosis is a major threat for patients suffering from chronic granulomatous disease (CGD). Although Aspergillus fumigatus is the most commonly encountered Aspergillus species, the presence of A. nidulans appears to be disproportionately high in CGD patients. The purpose of this study was to investigate the involvement of the NADPH oxidase and the resulting reactive oxygen species (ROS) in host defense against fungi and to clarify their relationship toward A. nidulans. Murine CGD alveolar macrophages (AM) and polymorphonuclear leukocytes (PMN) and peripheral blood mononuclear cells (PBMC) from healthy controls and CGD patients were challenged with either A. fumigatus or A. nidulans. Analysis of the antifungal effects of ROS revealed that A. nidulans, in contrast to A. fumigatus, is not susceptible to ROS. In addition, infection with live A. nidulans did not result in any measurable ROS release. Remarkably, human CGD PMN and PBMC and murine CGD AM were at least equipotent at arresting conidial germination compared to healthy controls. Blocking of the NADPH oxidase resulted in significantly reduced damage of A. fumigatus but did not affect A. nidulans hyphae. Furthermore, the microbicidal activity of CGD PMN was maintained toward A. nidulans but not A. fumigatus. In summary, antifungal resistance to A. nidulans is not directly ROS related. The etiology of A. nidulans infections in CGD cannot be explained by the simple absence of the direct microbicidal effect of ROS. In vivo, the NADPH oxidase is a critical regulator of innate immunity whose unraveling will improve our understanding of fungal pathogenesis in CGD.

Indexed as

AnimalsAspergillus nidulansFemaleHumansHydrogen PeroxideHyphaeLeukocytes, MononuclearMaleMembrane GlycoproteinsMiceNADPH Oxidase 2NADPH OxidasesNeutrophilsReactive Oxygen SpeciesCybb protein, mouseHydrogen PeroxideMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesReactive Oxygen Species

Identifiers

PMID21078850
PMCPMC3028853
OpenAlexW2102373264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.